Rachel Bachar

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas et al. · The Lancet Diabetes & Endocrinology · 2023 · 40 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +11

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Saul N. Faust, Richard Haynes, Christine E. Jones et al. · The Lancet Child & Adolescent Health · 2024 · 38 citations · Full text

Life Sciences, Immunology, Pediatrics +15

Premalignant lesions of the uterine cervix in a large cohort of Israeli Jewish women

Oscar Sadan, Eduardo Schejter, Shimon Ginath et al. · Archives of Gynecology and Obstetrics · 2004 · 33 citations

Medicine, Gynecology, Pathology +16

Treatment of high-grade squamous intraepithelial lesions: A “see and treat” versus a three-step approach

Oscar Sadan, Havazelet Yarden, Eduardo Schejter et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2006 · 29 citations

Medicine, Oncology, Pathology +11

Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective

Nava Siegelmann‐Danieli, Itzhak Katzir, Janet Vesterman Landes et al. · Breast Cancer Research and Treatment · 2017 · 29 citations · Full text

Medicine, Endocrinology, Oncology +14